InvestorsHub Logo
Followers 19
Posts 1026
Boards Moderated 0
Alias Born 04/15/2014

Re: Krysti post# 61531

Friday, 08/07/2015 8:00:19 AM

Friday, August 07, 2015 8:00:19 AM

Post# of 68830
Eyetalk365 DID NOT 'purchased' REVO patents, Kristy. What Eyetalk365 **PURCHASED was an exclusive LICENSE AGREEMENT....... A LEASE of the PATENT RIGHTS in effect and binding, but SUBJECT to TERMINATION/Cancellation if Performance provisions are not maintained and other BINDING agreement PROVISIONS...........As with an AUTO LEASE (an example that may be easier to grasp) the TITLE is TRANSFERRED to the LEASING PARTY...(subject to performance of terms) until TERMINATION of said LEASE.........This is CLEARLY SPELLED OUT in the disclosure of TERMS in the EXCLUSIVE LICENSE AGREEMENT SALE.........Please explain the benefit to ANYONE to Quote "FLOAT NOTES" starting in 2011 thru 2013 only to RETIRE them and LOSE SALARY and STOCK CONVERSION options for SALARY EARNED for that period......that is such a STRETCH it defies LOGIC !!!!!! ( i have suspected as much for some time however)......................It was no surprise that the 'purchase' of the license by Eyetalk365 statement is twisted to appear as a SALE of "PATENTS" rather than a **SALE OF ENFORCEMENT and MARKETING of PATENT RIGHTS** as it ACTUALLY IS (and subject to termination) !! How convenient to ignore the 40% Member Interest (in Eyetalk365) REVO received, ON TOP of the 40% of ALL GROSS REVENUE. That so called "SHAM" virtually IMMEDIATELY took FREE RIDERS to COURT and produced SETTLEMENTS to the ***UNDEFENSABLE INFRINGEMENT CLAIMS*** leveled by EYETALK/REVO Lawyers.........You ** suspect** the SEC looked into this, but have NO DOCUMENTED PROOF, only QUESTIONS ABOUT to rely on as FACT...... basically meaning **LACK of UNDERSTANDING** **no surprise**

Anything you say CAN and WILL BE researched

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.